Literature DB >> 8959145

Evaluation of a social health intervention among homeless tuberculosis patients.

E Díez1, J Clavería, T Serra, J A Caylà, J M Jansà, R Pedro, J R Villalbí.   

Abstract

SETTING: Homeless and other fringe groups are a priority in the global strategies of tuberculosis prevention and control in big cities, as a consequence of their generally poor adherence to treatment and concurrent multiple social and health problems.
OBJECTIVE: To evaluate a social care and health follow-up programme targeting homeless tuberculosis patients in Ciutat Vella District, Barcelona, which covered 210 patients from 1987 to 1992. During directly observed treatment, primary health care and, if necessary, accommodation was provided.
DESIGN: The differential tuberculosis incidence rate between Ciutat Vella and the other districts of Barcelona, the percentage of successfully completed treatments and the days of hospitalization saved by the programme were measured.
RESULTS: There was a significant decrease in the tuberculosis incidence rate among homeless patients in Ciutat Vella (from 32.4 per 10(5) inhabitants in 1987, to 19.8 per 10(5) in 1992, P = 0.03), compared to an unchanged rate elsewhere (1.6 per 10(5) inhabitants in 1987, compared to 1.7 per 10(5) in 1992, P = 0.34). A smaller than expected proportion, 19.6%, of patients failed to complete their treatment, and a decrease in the mean period of hospitalization for tuberculosis in the district hospital was recorded, falling from a mean 27.1 days in 1986 to a mean 15.7 days in 1992.
CONCLUSION: The programme appears to be both effective and efficient, as it has enabled a large number of homeless patients to complete their treatment successfully, at the same time saving twice the amount of funds invested.

Entities:  

Mesh:

Year:  1996        PMID: 8959145     DOI: 10.1016/s0962-8479(96)90114-8

Source DB:  PubMed          Journal:  Tuber Lung Dis        ISSN: 0962-8479


  6 in total

1.  Molecular fingerprinting of Mycobacterium tuberculosis and risk factors for tuberculosis transmission in Paris, France, and surrounding area.

Authors:  M C Gutiérrez; V Vincent; D Aubert; J Bizet; O Gaillot; L Lebrun; C Le Pendeven; M P Le Pennec; D Mathieu; C Offredo; B Pangon; C Pierre-Audigier
Journal:  J Clin Microbiol       Date:  1998-02       Impact factor: 5.948

2.  The Experience of Implementing Urban HEART Barcelona: a Tool for Action.

Authors:  Ana M Novoa; Glòria Pérez; Albert Espelt; Cynthia Echave; Patricia G de Olalla; M Jesús Calvo; Maribel Pasarín; Èlia Diez; Carme Borrell; M Jesús Calvo; Berta Cormenzana; Imma Cortés; Èlia Diez; Cynthia Echave; Albert Espelt; Patrícia G de Olalla; Josep Gòmez; Ana M Novoa; Montserrat Pallarès; Glòria Pérez; Maica Rodríguez-Sanz
Journal:  J Urban Health       Date:  2018-10       Impact factor: 3.671

3.  Contacts of underserved tuberculosis patients have higher odds of TB disease in North West England: a cohort study.

Authors:  T Wingfield; P MacPherson; P Sodha; A Tucker; J Mithoo; S B Squire; P Cleary
Journal:  Int J Tuberc Lung Dis       Date:  2019-03-01       Impact factor: 2.373

4.  Community based interventions for the prevention and control of tuberculosis.

Authors:  Ahmed Arshad; Rehana A Salam; Zohra S Lassi; Jai K Das; Imama Naqvi; Zulfiqar A Bhutta
Journal:  Infect Dis Poverty       Date:  2014-08-01       Impact factor: 4.520

Review 5.  Responding to pandemics and other disease outbreaks in homeless populations: A review of the literature and content analysis.

Authors:  Jordan Babando; Danika A Quesnel; Kyler Woodmass; Arielle Lomness; John R Graham
Journal:  Health Soc Care Community       Date:  2021-04-06

6.  "Treatment is of primary importance, and social assistance is secondary": A qualitative study on the organisation of tuberculosis (TB) care and patients' experience of starting and staying on TB treatment in Riga, Latvia.

Authors:  Karina Kielmann; Nicole Vidal; Vija Riekstina; Maria Krutikov; Marieke J van der Werf; Evita Biraua; Predrag Duric; David A J Moore
Journal:  PLoS One       Date:  2018-10-17       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.